Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study)

Eduard Vieta, Elena Blasco-Colmenares, Maria Luisa Figueira, Jens M Langosch, Miriam Moreno-Manzanaro, Esteban Medina, WAVE-bd Study Group, Eduard Vieta, Elena Blasco-Colmenares, Maria Luisa Figueira, Jens M Langosch, Miriam Moreno-Manzanaro, Esteban Medina, WAVE-bd Study Group

Abstract

Background: Studies in bipolar disorder (BD) to date are limited in their ability to provide a whole-disease perspective--their scope has generally been confined to a single disease phase and/or a specific treatment. Moreover, most clinical trials have focused on the manic phase of disease, and not on depression, which is associated with the greatest disease burden. There are few longitudinal studies covering both types of patients with BD (I and II) and the whole course of the disease, regardless of patients' symptomatology. Therefore, the Wide AmbispectiVE study of the clinical management and burden of Bipolar Disorder (WAVE-bd) (NCT01062607) aims to provide reliable information on the management of patients with BD in daily clinical practice. It also seeks to determine factors influencing clinical outcomes and resource use in relation to the management of BD.

Methods: WAVE-bd is a multinational, multicentre, non-interventional, longitudinal study. Approximately 3000 patients diagnosed with BD type I or II with at least one mood event in the preceding 12 months were recruited at centres in Austria, Belgium, Brazil, France, Germany, Portugal, Romania, Turkey, Ukraine and Venezuela. Site selection methodology aimed to provide a balanced cross-section of patients cared for by different types of providers of medical aid (e.g. academic hospitals, private practices) in each country. Target recruitment percentages were derived either from scientific publications or from expert panels in each participating country. The minimum follow-up period will be 12 months, with a maximum of 27 months, taking into account the retrospective and the prospective parts of the study. Data on demographics, diagnosis, medical history, clinical management, clinical and functional outcomes (CGI-BP and FAST scales), adherence to treatment (DAI-10 scale and Medication Possession Ratio), quality of life (EQ-5D scale), healthcare resources, and caregiver burden (BAS scale) will be collected. Descriptive analysis with common statistics will be performed.

Discussion: This study will provide detailed descriptions of the management of BD in different countries, particularly in terms of clinical outcomes and resources used. Thus, it should provide psychiatrists with reliable and up-to-date information about those factors associated with different management patterns of BD.

Trial registration no: ClinicalTrials.gov: NCT01062607.

Figures

Figure 1
Figure 1
Study design.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) Washington; 2000.
    1. Kupfer DJ, (Ed) Epidemiology and clinical course of bipolar disorder. 2004.
    1. Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano GB, Wittchen HU. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15(4):425–434. doi: 10.1016/j.euroneuro.2005.04.011.
    1. Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry. 1995;56(1):5–13.
    1. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Am J Psychiatry. 2006;163(2):217–224. doi: 10.1176/appi.ajp.163.2.217.
    1. Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 2007;9(1-2):183–196. doi: 10.1111/j.1399-5618.2007.00430.x.
    1. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares-Seisdedos R, Ayuso-Mateos JL. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1-2):103–113. doi: 10.1111/j.1399-5618.2007.00327.x.
    1. Chakrabarti S, Gill S. Coping and its correlates among caregivers of patients with bipolar disorder: a preliminary study. Bipolar Disord. 2002;4(1):50–60. doi: 10.1034/j.1399-5618.2002.01167.x.
    1. Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol. 1991;4(4):204–210. doi: 10.1177/089198879100400405.
    1. Stensland MD, Jacobson JG, Nyhuis A. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care. J Affect Disord. 2007;101(1-3):187–193. doi: 10.1016/j.jad.2006.11.019.
    1. Nattinger AB, Pezzin LE, Sparapani RA, Neuner JM, King TK, Laud PW. Heightened attention to medical privacy: challenges for unbiased sample recruitment and a possible solution. Am J Epidemiol. 2010;172(6):637–644. doi: 10.1093/aje/kwq220.
    1. Denicoff KD, Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, Suppes T, Altshuler LL, Kupka R, Frye MA, Hatef J, Brotman MA, Post RM. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med. 2000;30(6):1391–1397. doi: 10.1017/S0033291799002810.
    1. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73(3):159–171. doi: 10.1016/S0165-1781(97)00123-6.
    1. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177–183. doi: 10.1017/S0033291700050182.
    1. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13(4):489–495.
    1. EuroQol. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16(3):199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Rosa AR, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5. doi: 10.1186/1745-0179-3-5.
    1. Reinhard SC, Gubman GD, Horwitz AV, Minsky S. Burden assessment scale for families of the seriously mentally ill. Evaluation and Program Planning. 1994;17(3):261–269. doi: 10.1016/0149-7189(94)90004-3.
    1. Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord. 2007;9(1-2):45–52. doi: 10.1111/j.1399-5618.2007.00325.x.
    1. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J. The Stanley Foundation Bipolar Network. I. Rationale and methods. Br J Psychiatry Suppl. 2001;41:s169–176. doi: 10.1192/bjp.178.41.s169.
    1. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) Biol Psychiatry. 2003;53(11):1028–1042. doi: 10.1016/S0006-3223(03)00165-3.
    1. Vieta E, de Arce R, Jimenez-Arriero MA, Rodriguez A, Balanza V, Cobaleda S. Detection of subclinical depression in bipolar disorder: a cross-sectional, 4-month prospective follow-up study at community mental health services (SIN-DEPRES) J Clin Psychiatry. 2010;71(11):1465–74. doi: 10.4088/JCP.09m05177gre.
    1. Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1-2):156–160. doi: 10.1016/j.jad.2009.05.014.
    1. Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285–297. doi: 10.1159/000228249.
    1. Perlick D, Clarkin JF, Sirey J, Raue P, Greenfield S, Struening E, Rosenheck R. Burden experienced by care-givers of persons with bipolar affective disorder. Br J Psychiatry. 1999;175:56–62. doi: 10.1192/bjp.175.1.56.
    1. Perlick DA, Hohenstein JM, Clarkin JF, Kaczynski R, Rosenheck RA. Use of mental health and primary care services by caregivers of patients with bipolar disorder: a preliminary study. Bipolar Disord. 2005;7(2):126–135. doi: 10.1111/j.1399-5618.2004.00172.x.
    1. Perlick DA, Rosenheck RA, Clarkin JF, Maciejewski PK, Sirey J, Struening E, Link BG. Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatr Serv. 2004;55(9):1029–1035. doi: 10.1176/appi.ps.55.9.1029.
    1. Reinares M, Vieta E, Colom F, Martinez-Aran A, Torrent C, Comes M, Goikolea JM, Benabarre A, Daban C, Sanchez-Moreno J. What really matters to bipolar patients' caregivers: sources of family burden. J Affect Disord. 2006;94(1-3):157–163. doi: 10.1016/j.jad.2006.04.022.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner